NSE filing, NSE: VILINBIO. Summary written from the filing by ALFA Finder's alert engine.
Vilin Bio Med Ltd: key numbers
- Share price
- ₹50.85
- Market cap
- ₹77.55 Cr
- Revenue (annual)
- ₹42.26 Cr
- Net profit (annual)
- ₹1.93 Cr
- P/E (TTM)
- 40.2×Sector 46.1×
- Promoter holding
- 56.65%+0.00% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vilin Bio Med Ltd
All →Vilin Bio Med Other Announcement
Vilin Bio Med voluntarily filed its Integrated Corporate Governance Report for the quarter ended September 30, 2026, despite being exempt as an NSE Emerge listed entity. No material business transaction or decision is disclosed.
Vilin Bio Med Acquisition
Vilin Bio Med held NCLT-convened meetings to approve a scheme of amalgamation with Chemgenix Laboratories. Voting results remain pending in the Scrutinizer's report.
Vilin Bio Med Merger & Restructuring
Vilin Bio Med Limited announced an NCLT-convened meeting on October 15, 2026, to vote on a Scheme of Arrangement with Chemgenix Laboratories Private Limited.
Vilin Bio Med Acquisition
Vilin Bio Med disclosed NCLT Hyderabad allowed its amalgamation with Chemgenix Laboratories Pvt Ltd. The order directs convening shareholder and creditor meetings for both companies.
Vilin Bio Med Annual General Meeting
Vilin Bio Med Limited conducted its 20th Annual General Meeting on September 2, 2026, to discuss financial statements, director appointments, and related party transactions.
Vilin Bio Med Merger & Restructuring
Vilin Bio Med received a 'No Objection' observation letter from the NSE regarding its merger with Chemgenix Laboratories. The scheme remains subject to further statutory and creditor approvals.
Other board meeting date announcements
All →RR Securities Board Meeting Date
R R Securities Limited intimated a board meeting on 06 Nov 2026 to consider unaudited standalone results for the quarter and half year ended September 2026. Trading window closes 01 Oct to 09 Nov 2026.
Rico Auto Industries Board Meeting Date
Rico Auto Industries Limited intimated a board meeting on 06 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window stays closed from 01 Oct 2026 until 48 hours after results.
Oil Country Tubular Board Meeting Date
Oil Country Tubular Limited intimated a board meeting on 05 Nov 2026 to consider unaudited standalone financial results for the quarter ended September 2026. Trading window closes 01 Oct to 07 Nov 2026.
Gajanand International Board Meeting Date
Gajanand International Ltd will hold a board meeting on 4 Nov 2026 to consider unaudited H1 FY27 results. This is an advance intimation; no decision has been taken yet.
Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.